تجاوز إلى المحتوى الرئيسي
drug protocol number
D9185C00001
drug sponsor
AstraZeneca
drug study
Tozorakimab (MEDI3506)
drug trial site
King Abdulaziz Medical City NG (Jeddah), King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Riyadh)
drug status
Ongoing
drug phase